These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 18558621

  • 21. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK, Kitching AR, Jones LK, Holdsworth SR.
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [Abstract] [Full Text] [Related]

  • 22. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
    Odobasic D, Kitching AR, Semple TJ, Holdsworth SR.
    J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.
    Ka SM, Sytwu HK, Chang DM, Hsieh SL, Tsai PY, Chen A.
    J Am Soc Nephrol; 2007 Sep; 18(9):2473-85. PubMed ID: 17687076
    [Abstract] [Full Text] [Related]

  • 25. Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis.
    Datta PK, Reddy RS, Lianos EA.
    Inflammation; 2001 Dec; 25(6):351-9. PubMed ID: 11831438
    [Abstract] [Full Text] [Related]

  • 26. Tissue transglutaminase overexpression in the brain potentiates calcium-induced hippocampal damage.
    Tucholski J, Roth KA, Johnson GV.
    J Neurochem; 2006 Apr; 97(2):582-94. PubMed ID: 16539654
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.
    Choi HK, Pokharel YR, Lim SC, Han HK, Ryu CS, Kim SK, Kwak MK, Kang KW.
    Toxicol Appl Pharmacol; 2009 Nov 01; 240(3):377-84. PubMed ID: 19647758
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of losartan on cyclooxygenase-2 expression in normal human mesangial cells and kidneys of rats with diabetic nephropathy.
    Zhou QL, Peng WS, Yuichiro Y, Liu ZC, Yang JH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 01; 33(9):790-9. PubMed ID: 18812657
    [Abstract] [Full Text] [Related]

  • 33. Latent TGF-beta1 protects against crescentic glomerulonephritis.
    Huang XR, Chung AC, Zhou L, Wang XJ, Lan HY.
    J Am Soc Nephrol; 2008 Feb 01; 19(2):233-42. PubMed ID: 18216320
    [Abstract] [Full Text] [Related]

  • 34. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells.
    Li X, McFarland DC, Velleman SG.
    Domest Anim Endocrinol; 2008 Oct 01; 35(3):263-73. PubMed ID: 18650056
    [Abstract] [Full Text] [Related]

  • 35. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis.
    Hochegger K, Siebenhaar F, Vielhauer V, Heininger D, Mayadas TN, Mayer G, Maurer M, Rosenkranz AR.
    Eur J Immunol; 2005 Oct 01; 35(10):3074-82. PubMed ID: 16180252
    [Abstract] [Full Text] [Related]

  • 36. Validated sandwich ELISA for the quantification of tissue transglutaminase in tissue homogenates and cell lysates of multiple species.
    Brevé JJ, Drukarch B, van Strien M, van Dam AM.
    J Immunol Methods; 2008 Mar 20; 332(1-2):142-50. PubMed ID: 18279887
    [Abstract] [Full Text] [Related]

  • 37. Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis.
    Bassuk JA, Pichler R, Rothmier JD, Pippen J, Gordon K, Meek RL, Bradshaw AD, Lombardi D, Strandjord TP, Reed M, Sage EH, Couser WG, Johnson R.
    Kidney Int; 2000 Jan 20; 57(1):117-28. PubMed ID: 10620193
    [Abstract] [Full Text] [Related]

  • 38. Uteroglobin induces the development and cellular proliferation of the mouse early embryo.
    Riffo M, González KD, Nieto A.
    J Exp Zool A Ecol Genet Physiol; 2007 Jan 01; 307(1):28-34. PubMed ID: 17094107
    [Abstract] [Full Text] [Related]

  • 39. Localization of tissue transglutaminase (tTG) in kidney of ICR-derived glomerulonephritis (ICGN) mice.
    Miyamoto Y, Myomoto A, Sakaguchi Y, Yamaguchi-Yamada M, Uchio-Yamda K, Manabe N.
    Exp Anim; 2009 Jul 01; 58(4):375-82. PubMed ID: 19654435
    [Abstract] [Full Text] [Related]

  • 40. Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases.
    Bailey CD, Graham RM, Nanda N, Davies PJ, Johnson GV.
    Mol Cell Neurosci; 2004 Mar 01; 25(3):493-503. PubMed ID: 15033177
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.